Search Within

Richard Jirui Lin

Formats
  1. Meeting Abstract (67)
  2. Journal Article (41)
  3. Research Letter (10)
  4. Review (8)
  5. Book Section (2)
  6. Guidelines (2)
  7. Editorial (1)
Groups
  1. Department of Medicine (131)
  2. Hematologic Malignancies, Division of (131)
  3. Center for Hematologic Malignancies (118)
  4. Bone Marrow Transplant (116)
  5. Survivorship Research (114)
  6. CTCR Scholars (108)

More Groups

People
  1. Miguel-Angel Perales (102)
  2. Parastoo Dahi (92)
  3. Sergio Giralt (86)
  4. Gunjan Shah (84)
  5. Michael Scordo (81)
  6. Sean Devlin (75)

More People

Years
  1. 2025 (9)
  2. 2024 (20)
  3. 2023 (34)
  4. 2022 (18)
  5. 2021 (12)
  6. 2020 (16)

More Years

Publications
  1. Blood (39)
  2. Transplantation and Cellular Therapy (16)
  3. Bone Marrow Transplantation (15)
  4. Biology of Blood and Marrow Transplantation (10)
  5. Blood Advances (9)
  6. Hematological Oncology (4)

More Publications

Publishers
  1. American Society of Hematology (50)
  2. Elsevier Inc. (31)
  3. Nature Publishing Group (21)
  4. Wiley Blackwell (4)
  5. American Society of Clinical Oncology (3)
  6. Ferrata Storti Foundation (3)

More Publishers

Results (131)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses
    Meeting Abstract

    Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase II study of longitudinal geriatric assessment with risk-adapted interventions to reduce non-relapse mortality in allogeneic hematopoietic cell transplantation for older patients with advanced myeloid malignancies
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Brown, S.; Hanley, D. M.; Engstler, D. E.; Politikos, I.; Gyurkocza, B.; Tamari, R.; Papadopoulos, E. B.; Saldia, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Long-term follow up of a prospective pilot study of an α/β T-lymphocyte depleted graft conditioned with a reduced intensity regimen in patients with hematologic malignancies
    Meeting Abstract

    Hughes, C. F. M.; Lin, R. J.; Devlin, S. M.; Shaffer, B. C.; Jakubowski, A. A.; Talla, V.; Saldia, A.; Gyurkocza, B.; Papadopoulos, E. B.; Giralt, S. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase II study of pharmacokinetic model-based ATG dosing to improve survival through enhanced immune reconstitution in patients undergoing ex vivo CD34-selected allogeneic HCT (PRAISE-IR)
    Meeting Abstract

    Scordo, M.; Perales, M. A.; Mauguen, A.; Lin, A.; Kunvarjee, B.; Bieler, J.; Nguyen, L. K.; Paes Pena, M.; Cho, C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Site-specific responses and extranodal involvement implications in large B-cell lymphomas treated with CD19-CART therapy
    Meeting Abstract

    Luna de Abia, A.; Devlin, S. M.; Flynn, J.; Corona De Lapuerta, M.; Luttwak, E.; Landego, I.; Dahi, P. B.; Lin, R. J.; Parascondola, A.; Palomba, M. L.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • A proof-of-principle study of split-course bridging radiotherapy (SC-BRT) prior to commercial CAR T-cell therapies for relapsed or refractory B-cell lymphomas: Results from phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K.; Boardman, A.; Dahi, P. B.; Lin, R. J.; Shah, G. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Hematologic malignancies
    Book Section

    Lin, R. J.
    In Wasserman, M. R.; Bakerjian, D.; Linnebur, S.; Brangman, S.; Cesari, M.; Rosen, S. (Eds.) Geriatric Medicine: A Person Centered Evidence Based Approach. 5th ed (2024)

    Fulltext@MSK | Save